Jonathan Yingling
2017
In 2017, Jonathan Yingling earned a total compensation of $1.1M as Senior Vice President, Chief Scientific Officer at Idera Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $144,296 |
|---|---|
| Option Awards | $577,782 |
| Salary | $348,542 |
| Other | $31,277 |
| Total | $1,101,897 |
Yingling received $577.8K in option awards, accounting for 52% of the total pay in 2017.
Yingling also received $144.3K in non-equity incentive plan, $348.5K in salary and $31.3K in other compensation.
Rankings
In 2017, Jonathan Yingling's compensation ranked 8,530th out of 14,666 executives tracked by ExecPay. In other words, Yingling earned more than 41.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,530 out of 14,666 | 42nd |
Division Manufacturing | 3,237 out of 5,772 | 44th |
Major group Chemicals And Allied Products | 1,078 out of 2,075 | 48th |
Industry group Drugs | 853 out of 1,731 | 51st |
Industry Biological Products, Except Diagnostic Substances | 153 out of 313 | 51st |
Source: SEC filing on April 25, 2019.
Yingling's colleagues
We found five more compensation records of executives who worked with Jonathan Yingling at Idera Pharmaceuticals in 2017.
2017
Vincent Milano
Idera Pharmaceuticals
Chief Executive Officer
2017
Joanna Horobin
Idera Pharmaceuticals
Chief Medical Officer
2017
R Fletcher
Idera Pharmaceuticals
Senior Vice President, Business Development and Strategy
2017
Louis Arcudi
Idera Pharmaceuticals
Chief Financial Officer
2017
John Kirby
Idera Pharmaceuticals